Market news
Headlines, company news and fresh SEC filings, updated every morning. Stocks we cover show their Quant Score and today’s move — tap one to see the full picture.
Updated daily
Asset-light operations will generate 60% of expected 2026 revenue. Ryder raised its 2026 comparable earnings forecast to $14.85 to $15.05.
Phase I/II NECVAX-NEO1 trial in patients with triple-negative breast cancer confirm its potential safety and immunogenicity and provide clinical proof-of-concep
TOKYO, Oct 23, 2026 - (JCN Newswire) - Osaka Gas Co., Ltd. ("Osaka Gas") and Mitsubishi Heavy Industries, Ltd. ("MHI") today commenced operation of CO2NNEX?(1),
Ryder System (NYSE:R) reported better-than-expected third-quarter financial results on Thursday.
Ryder System NYSE: R reported third-quarter results that included a 21% increase in comparable earnings per share, citing strategic initiatives, contractual revenue growth and improving conditions in used vehicle sales and commercial rental.
Ryder System, Inc. (R) Q3 2026 Earnings Call Transcript
MIDLAND, VA / ACCESS Newswire / October 22, 2026 / Smith-Midland Corporation (NASDAQ:SMID), a leading manufacturer of innovative precast concrete products for transportation, infrastructure, and building construction, has secured a $2.2 million contract to manufacture and supply its proprietary SlenderWall® architectural precast wall system for the new Drew Middle School in Stafford County, Virginia. Manufacturing is scheduled to begin at Smith-Midland's Virginia facility in February 2027, with installation scheduled to start in May 2027.
The headline numbers for Ryder (R) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Ryder (R) came out with quarterly earnings of $4.33 per share, beating the Zacks Consensus Estimate of $4.17 per share. This compares to earnings of $3.57 per share a year ago.
MIAMI--(BUSINESS WIRE)--Ryder System, Inc. (NYSE: R) reported results for the three months ended September 30 as follows: Earnings Before Taxes Earnings Diluted Earnings Per Share (In millions, except EPS) 2026 2025 2026 2025 2026 2025 Continuing operations (GAAP) $ 226 190 $ 162 139 $ 4.16 3.33 Comparable (non-GAAP) $ 234 200 $ 169 149 $ 4.33 3.57 Total and operating revenue for the three months ended September 30 were as foll.
Brisbane, Queensland, Australia--(Newsfile Corp. - October 21, 2026) - Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to announce that it has commenced providing its fast-charging G®CELLS battery pouch cells to potential customers for early-stage testing and evaluation.
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Ryder (R), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2026.
Ryder System, Inc. R is scheduled to release third-quarter 2026 results on Oct. 22, before market open.
Multi-year global partnership unites two American challengers built to unlock the world's most abundant energy resource and redefine performance on the world stage Multi-year global partnership unites two American challengers built to unlock the world's most abundant energy resource and redefine performance on the world stage
Bremen, Indiana--(Newsfile Corp. - October 15, 2026) - Digger Specialties Inc. (DSI), the industry's leader in the production of aluminum railing, offers property owners a choice of two elegant cable railing systems. Cable railing has become an increasingly popular option for decks, patios, balconies, and terraces as well as outdoor and indoor stairways.
~Newly issued patents continue to solidify the company's position as an innovator in the rapidly growing sacro-pelvic fusion market~ ~Portfolio now includes 38 issued U.S. patents and 9 international patents, with 31 applications pending~ ~Company anticipates continued additions to its IP portfolio along with several product launches in the coming quarters~ LOS GATOS, CA / ACCESS Newswire / October 15, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients suffering from certain sacro-pelvic disorders, today announced that the U.S. Patent and Trademark Office (USPTO) has issued 8 new patents to the Company so far in 2026 fiscal year. With these additions, Tenon holds 38 issued U.S. patents and 9 international patents and has 31 U.S. and foreign patent applications pending.
Shares of Ryder System, Inc. (NYSE: R - Get Free Report) have been assigned an average rating of "Moderate Buy" from the twelve ratings firms that are presently covering the stock, MarketBeat Ratings reports. Four analysts have rated the stock with a hold recommendation, seven have issued a buy recommendation and one has issued a strong
Maven CEO and founder Kate Ryder tells Julia Boorstin during the latest "CNBC Changemakers" podcast that the health benefits firm was close to maxing out its full-year budget for AI use by August. She says overall return on investment remains unproven, but she has no doubts about how transformative the technology will be, especially in women's healthcare where data has long been lacking.
R's expansion initiatives, rising earnings estimates and growing shareholder returns bolster its prospects, with shares gaining 32.1% over the past year.
In this episode of CNBC Changemakers, Julia Boorstin speaks with Maven Clinic founder and CEO Kate Ryder about using AI to expand access to women's and family health care while keeping care human. Ryder explains how Maven supports patients through fertility, pregnancy, postpartum and menopause, and how AI can improve knowledge sharing, patient care and price transparency.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Engagement with leading orthopedic surgeons and cartilage repair specialists highlights growing awareness of GelrinC's off-the-shelf regenerative technology GelrinC is CE Mark approved in Europe, where Regentis is expanding its network of Centers of Excellence to support surgeon training and commercialization efforts European clinical sites also support the Company's ongoing U.S. FDA pivotal Phase III trial HERZLIYA, ISRAEL / ACCESS Newswire / October 12, 2026 / Regentis Biomaterials Ltd. ("Regentis" or the "Company") (NYSE American:RGNT), a regenerative medicine company focused on innovative tissue repair solutions, today announced strong interest and engagement from orthopedic surgeons, physicians and cartilage repair specialists who visited the Company's booth at the 8th International Cartilage Regeneration & Joint Preservation Society (ICRS) Summit, held October 8-10, 2026, in Porto, Portugal.
Second of Four Planned Modules Moves Rolling FDA Review Forward Advances Toward Targeted Completion of the Final Clinical Module Submission in Q2 2027 White Bear Lake, Minnesota--(Newsfile Corp. - October 12, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced the submission of the second module of its Modular Premarket Approval ("PMA") application to the U.S. Food and Drug Administration ("FDA") for the Acclaim® cochlear implant, which has received FDA Breakthrough Device Designation. The second module, which included primarily engineering information, follows the Company's submission of the first module on June 30, 2026.
Humana adds ChemoFx® to its Medicaid Pharmacogenomics Testing coverage policy TAMPA, FL / ACCESS Newswire / October 12, 2026 / DataMeds AI, Inc . (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company vertically integrating its Health IT and physical infrastructure together with its super intelligence platform EinsteinRx™ and smart contracts platform PharmacyChain™, today announced that its recently acquired CLIA-certified precision oncology laboratory subsidiary Helomics Corporation has received a Medicaid coverage determination in gynecologic cancers for the ChemoFx® Assay, a commercially available chemoresponse test that measures how a patient's live tumor cells respond to chemotherapy agents, in gynecologic cancers.
MIAMI--(BUSINESS WIRE)--The Board of Directors of Ryder System, Inc. (NYSE: R) declared a regular quarterly cash dividend of $1.01 per share of common stock to be paid on December 18, 2026 to shareholders of record on November 23, 2026. This is Ryder's 201st consecutive quarterly cash dividend – marking 50 years of uninterrupted dividend payments. About Ryder System, Inc. Ryder System, Inc. (NYSE: R) is a nearly $13 billion leading provider of outsourced logistics and transportation services th.
--Ribbon Cutting and Guest Giveaways Mark Kickoff for Largest Single-property Jackpot Blitz(R) Deployment to Date, Now Open for Play-- Vancouver, British Columbia and Temecula, California--(Newsfile Corp. - October 9, 2026) - Jackpot Digital Inc. (TSXV: JJ) (OTCQB: JPOTF) (Frankfurt Stock Exchange: LVH3) ("Jackpot Digital" or the "Company"), the world's leading manufacturer of dealerless multiplayer electronic poker tables, and Pechanga Resort Casino, one of North America's largest and most respected Tribal gaming destinations, are pleased to jointly announce that eight (8) Jackpot Blitz® electronic poker tables are now open for play at Pechanga Resort Casino, located just outside of Temecula, California. Jackpot Digital and Pechanga Resort Casino Executive and Board Members Cut the Ribbon Marking the Opening of 8 New Digital Poker Games at Pechanga Resort Casino Outside Temecula, Calif.
Toronto, Ontario--(Newsfile Corp. - October 9, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical-stage pharmaceutical company dedicated to the research and development of proprietary Energy-Activated Small Molecules ("EASMs") for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to announce that the Company has been invited to present at the 2026 ThinkEquity Conference in New York. ThinkEquity is a boutique investment bank that has collectively financed over $50 billion of public and private capital raises, restructurings, mergers and acquisitions.
R expands its Northeast used truck sales network with new facilities in Newark and North Bergen, boosting customer access and its presence in key freight hubs.
Powering Every New Beginning: ODYSSEY® Battery Energizes Project REBORN's Mission NORTH EAST, PA / ACCESS Newswire / October 8, 2026 / NFI Empire, a fully owned subsidiary of Newport Gold, Inc. (OTCID:NWPG), today announced that ODYSSEY® Battery has joined Project Reborn-001 as a key technology partner. The custom vehicle build is heading to auction at The Red Bird Games in Brentwood, TN, with proceeds benefiting The Brett Boyer Foundation.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Source: Financial Modeling Prep · SEC EDGAR · filings from the last 12 months
RFinancial report · accepted 19d ago
